Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-22

FDA Approved: PODOFILOX — Supplemental Application (Padagis US LLC)

View source ↗

Summary

The FDA approved a supplemental application for Podofilox by Padagis US LLC, updating the product labeling through a supplemental filing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Podofilox (Podofilox)

Snippet

SUPPL AP for PODOFILOX (PODOFILOX)